This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Real validated RHOA Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-RHOA WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~21.8 kDa | |
| Observed band | ~22 kDa | |
| Gel | 5–20% (catalog M00207) | |
| Positive control | Adipose tissue (IHC candidate; verify WB) +4 more | |
| Negative control | Esophagus (IHC candidate; verify WB) |
| PTM | Toxin-dependent O-glycosylation + Phosphorylated | |
| Caveat | Toxin-dependent glycosylation | |
| Gene-set association | MSigDB Hallmark membership | |
| Isoform | 1 isoform(s) |
The M00207 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.
| Sample / lysate | human Hela, human U251, human SIHA (catalog M00207) |
| Gel % | 5–20% (catalog M00207) |
| Load | 30 ug; reducing conditions (catalog M00207) |
| Transfer | a nitrocellulose membrane at 150 mA for 50-90 minutes (catalog M00207) |
| Membrane | nitrocellulose membrane (catalog M00207) |
| Blocking | 5% non-fat milk/TBS for 1.5 hour at RT (catalog M00207) |
| Primary antibody | M00207 · 1:500 (catalog M00207) |
| Primary incubation | overnight at 4°C (catalog M00207) |
| Secondary antibody | goat anti-rabbit IgG-HRP, 1:5000 (catalog M00207) |
| Secondary incubation | 1.5 hour at RT (catalog M00207) |
| Wash | TBS-0.1%Tween 3 times with 5 minutes each (catalog M00207) |
| Detection | ECL (catalog M00207) |
RHOA is predicted at 21.8 kDa and observed at ~22 kDa; the small difference has no established cause in the supplied evidence.
| Band at ~22 kDa | RHOA signal consistent with the 21.8 kDa predicted protein; confirm identity with appropriate controls |
| Band slightly below the precursor | Possible cleavage of the annotated 191–193 propeptide; a visible difference is not established |
| Additional band near ~22 kDa after microbial infection | Could reflect toxin-dependent O-linked GlcNAc at Tyr34 or Thr37, or O-linked glucose at Thr37; band identity needs confirmation |
| No clear band near ~22 kDa | RHOA signal may be weak or absent in the tested sample |
| UniProt predicted mass | 21.8 kDa predicts a band close to the empirical ~22 kDa signal |
| Propeptide at residues 191–193 | Cleavage could make mature RHOA slightly smaller than its precursor; a resolved shift is unproven |
| Infection-dependent O-linked GlcNAc at Tyr34 | Photorhabdus PAU_02230 modification adds one sugar; a visible shift is unproven |
| Infection-dependent O-alpha-linked GlcNAc at Thr37 | C. novyi toxin TcdA modification adds one sugar; a visible shift is unproven |
| Infection-dependent O-linked glucose at Thr37 | C. difficile toxins TcdA and TcdB modify this site alternatively; a visible shift is unproven |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | RHOA recovery or abundance in the tested lysate may be low | Check lysate loading and extraction, then compare with a known positive lysate |
| Band higher than expected | The supplied features do not establish a larger RHOA species | Compare with a positive control and confirm identity using an independent RHOA antibody or RHOA depletion |
| Band lower than expected | The 191–193 propeptide may be cleaved, but its effect on migration is unproven | Confirm identity with an independent antibody or RHOA depletion |
| Broad smear instead of sharp band | The listed infection-dependent single-sugar sites do not establish a smear | Check transfer and sample quality, then verify RHOA specificity with an independent antibody or depletion |
| Multiple bands | No distinct isoform masses or resolved modification bands are supplied | Use RHOA depletion and a second antibody to identify the specific band |
| Weak or no signal | RHOA may be poorly recovered from the cell membrane or cytoskeleton | Check extraction and loading, and include a known positive lysate |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Adipose tissue | adipocytes | Medium | Protein (IHC) | HPA → |
| Adrenal gland | glandular cells | Medium | Protein (IHC) | HPA → |
| Breast | adipocytes | Medium | Protein (IHC) | HPA → |
| Caudate | glial cells | Medium | Protein (IHC) | HPA → |
| Cerebellum | cells in molecular layer | Medium | Protein (IHC) | HPA → |
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Esophagus | squamous epithelial cells | Not detected | Protein (IHC) | HPA → |
| Liver | cholangiocytes | Not detected | Protein (IHC) | HPA → |
| Oral mucosa | squamous epithelial cells | Not detected | Protein (IHC) | HPA → |
| Vagina | squamous epithelial cells | Not detected | Protein (IHC) | HPA → |
| Appendix | glandular cells | Low | Protein (IHC) | HPA → |
Deeper troubleshooting and optimisation questions for RHOA, answered from its protein features.
Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.
Three catalogued the supplier antibodies have Western blot images: M00207 for Rho A, M00207-1 for Rho A+B+C, and M00207-2 for Rho expression in HeLa lysate. The supplied evidence does not establish RHOA specificity for the latter two.
Which to pick: For a RHOA-focused blot, start with M00207, whose image is described as Rho A analysis. Choose M00207-1 if detecting Rho A, B, and C together is acceptable. M00207-2 has a HeLa lysate blot, but its cue does not specify RHOA.